Asthma currently affects an estimated 15 million Americans. A number of studies have found an
association between low dietary magnesium (Mg) intake and increased asthma incidence and
severity of symptoms. However, clinical intervention trials are necessary to directly assess
whether there is a true protective or preventative causal relationship between low Mg and
asthma. In our study, we will assess the effects of 6 1/2 months of oral Mg supplements or
placebo on clinical markers of asthma control, indirect biomarkers of inflammation, bronchial
hyperresponsiveness, and indices of oxidative defense and damage in subjects with mild to
moderate persistent asthma.
Phase:
Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)